Swedish Infrastructure Stock News

In recent weeks, the European markets have shown resilience with the STOXX Europe 600 Index rising by 0.62%, buoyed by positive geopolitical developments such as the U.S.-Iran agreement, despite mixed macroeconomic data and a eurozone trade deficit. As investors navigate this landscape, identifying high growth tech stocks in Europe involves looking for companies that exhibit strong innovation potential and adaptability to shifting economic conditions, especially in an environment where...

Ambea (OM:AMBEA) has, through its Danish subsidiary Altiden, agreed to build a new 88-place care home in Nivå, Denmark, under the framework of the Danish Elderly Care Act, highlighting expanding elderly care demand. See our latest analysis for Ambea. Recent price action around Ambea has been mixed. The 7-day share price return of 4.37% and 90-day share price return of 5.57% sit alongside a 30-day share price decline of 8.16%. At the same time, the 1-year total shareholder return of 26.07% and...

The European markets have shown a mixed performance, with the pan-European STOXX Europe 600 Index rising slightly by 0.62%, buoyed by positive geopolitical developments, while macroeconomic data remains varied across the region. For investors interested in smaller or newer companies, penny stocks—despite their somewhat outdated name—continue to hold potential for value and growth. By focusing on those with solid financial foundations and clear growth trajectories, these stocks can offer both...

With the business potentially at an important milestone, we thought we'd take a closer look at Egetis Therapeutics AB...

Region Skåne recently awarded Sweco AB a contract, worth up to SEK 225 million between 2026 and 2035, to plan and design a new emergency hospital campus in Helsingborg, while East Railway Ltd. selected Sweco and Finnmap Infra Oy to prepare the general plan for the Porvoo–Koria section of Finland’s planned East Railway. Together, these long-duration healthcare and rail infrastructure assignments reinforce Sweco’s role as a key consultant on complex public projects across the Nordics. We’ll...

H & M Hennes & Mauritz (OM:HM B) has put fresh numbers on the table for Q2 2026, reporting revenue of SEK54.8b and basic EPS of SEK2.49 as investors weigh the latest turn in its earnings cycle. Over the past few quarters, revenue has moved between SEK49.6b and SEK59.2b while quarterly EPS has ranged from SEK0.45 to SEK2.72, with trailing twelve month EPS at SEK7.68 on revenue of SEK220.7b. This gives investors a fuller view of how the top and bottom lines are tracking through recent trading...

In June 2026, the European stock market has shown mixed signals with the pan-European STOXX Europe 600 Index rising modestly by 0.62% over a four-day period, as investors react to geopolitical developments and mixed macroeconomic data. Amidst this environment, identifying stocks that may be trading below their fair value can be an opportunity for investors seeking potential gains; such stocks often exhibit strong fundamentals or are temporarily undervalued due to broader market conditions.

Cibus Nordic Real Estate AB (publ) ( STO:CIBUS ) is about to trade ex-dividend in the next 4 days. The ex-dividend date...

As the European market shows signs of optimism with the STOXX Europe 600 Index rising by 0.62% and major indexes like Germany’s DAX and France’s CAC 40 posting gains, investors are keenly observing opportunities amid mixed macroeconomic data. In this context, identifying undervalued stocks becomes crucial for those looking to capitalize on potential discrepancies between market price and intrinsic value, especially when economic indicators suggest room for strategic investments.

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Aquaticus...

Kallebäck Property Invest AB (publ) ( STO:KAPIAB ) stock is about to trade ex-dividend in 3 days. Typically, the...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...

As European markets respond to mixed macroeconomic data and recent geopolitical developments, the pan-European STOXX Europe 600 Index has shown modest gains, reflecting a cautiously optimistic investor sentiment. In this environment, identifying stocks that are trading below their estimated value can present compelling opportunities for investors seeking to capitalize on potential market inefficiencies.

As global markets navigate a complex landscape marked by steady interest rates in the U.S., a rate hike in Japan, and mixed economic signals from Europe and China, investors are keenly observing small-cap stocks for potential opportunities. The Russell 2000's notable year-to-date performance highlights the resilience of smaller companies amidst broader market fluctuations. In this environment, identifying stocks with strong fundamentals and growth potential can be key to uncovering...

In recent weeks, the European markets have shown mixed signals, with the pan-European STOXX Europe 600 Index posting a modest gain of 0.62% amid encouraging geopolitical developments and varied macroeconomic data. As investors navigate these fluctuations, identifying stocks that are potentially undervalued can be crucial, especially in the small-cap segment where insider buying may signal confidence in future performance.

European markets have shown mixed performance, with the pan-European STOXX Europe 600 Index rising modestly and macroeconomic data presenting a varied picture. Amidst these fluctuations, penny stocks have emerged as intriguing investment opportunities. Despite their vintage label, penny stocks can offer surprising value, especially when backed by strong financials and solid fundamentals.

Trade tensions between the West and China are back in focus as the EU weighs broader tariffs and tighter controls on imports, especially in chemicals and green technology. For investors, that puts onshoring and domestic manufacturing in Europe and the US under a brighter spotlight. Some stocks could see potential benefits if supply chains localize further, while others may face higher costs and uncertainty. This article looks at 3 stocks from our Onshoring and Domestic Manufacturing screener...

Telefonaktiebolaget LM Ericsson (OM:ERIC B) is in the spotlight after the board appointed long-time executive Per Narvinger as CEO and President, with David Hammarwall set to lead its core Networks business. See our latest analysis for Telefonaktiebolaget LM Ericsson. The latest executive reshuffle comes as Ericsson’s short term share price momentum has cooled. The 30 day share price return of 11.04% compares with a stronger year to date share price return of 26.78% and a 1 year total...

As of June 2026, the European markets have shown a mixed performance, with the pan-European STOXX Europe 600 Index rising modestly by 0.62% amid encouraging geopolitical developments and fluctuating macroeconomic data. Investors are navigating through these conditions by seeking opportunities in potentially undervalued stocks that might offer resilience and growth potential in an uncertain economic environment.

CTO transition puts Nordnet stock in focus Nordnet (OM:SAVE) is under the spotlight after CTO Elias Lindholm decided to step down, with long-time insiders Michel Cupurdija and Aleksandar Sekulic set to share the role as co-CTOs from June 26, 2026. See our latest analysis for Nordnet. Against this management change, Nordnet’s short term momentum has been firm, with a 1 month share price return of 10.37% and a year to date share price return of 31.90%. The 5 year total shareholder return of...

As of June 2026, the European market has shown a mixed performance, with the pan-European STOXX Europe 600 Index rising by 0.62% over four days, buoyed by positive developments in U.S.-Iran relations but tempered by a eurozone trade deficit and varied macroeconomic indicators across the region. In this environment, investors may look toward high-growth tech stocks that demonstrate resilience and innovation potential amid shifting economic landscapes and evolving market sentiments.

In June 2026, Sobi announced that new clinical and real-world data for Aspaveli, Doptelet, Gamifant and Vonjo across multiple blood disorders were presented at the European Hematology Association Congress in Stockholm. This broad data package, spanning long-term effectiveness, safety, treatment patterns and patient-reported outcomes, highlights how Sobi is building an evidence base around its core haematology portfolio beyond initial approvals. We’ll now examine how this expanded real-world...